Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Benedetto Bruno, Holger W. Auner, Gösta Gahrton, Laurent Garderet, Moreno Festuccia, Marco Ladetto, Roberto M. Lemoli, Massimo Massaia, Curly Morris, Antonio Palumbo, Stefan Schönland, Mario Boccadoro, Nicolaus Kröger

Research output: Contribution to journalArticlepeer-review

Abstract

The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25–26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.

Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalLeukemia and Lymphoma
DOIs
Publication statusAccepted/In press - Jan 6 2016

Keywords

  • Multiple myeloma
  • new drugs
  • stem cell transplantation

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)'. Together they form a unique fingerprint.

Cite this